Filing Details

Accession Number:
0001193805-25-000923
Form Type:
4/A
Zero Holdings:
No
Publication Time:
2025-06-20 17:15:45
Reporting Period:
2025-06-04
Filing Date:
2025-06-20
Accepted Time:
2025-06-20 17:15:45
Original Submission Date:
2025-06-06
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1280776 Immunic Inc. IMUX Pharmaceutical Preparations (2834) 562358443
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1773673 Daniel Vitt 1200 Avenue Of The Americas, Suite 200
New York NY 10036
Ceo And Director Yes Yes No No
Transaction Summary
Purchased: 15,000 shares Avg. Price: $0.77 Total Value: $11,550.00
Number of Shares After Transactions: 29,000 shares
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2025-06-04 15,000 $0.77 29,000 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option Acquisiton 2025-06-05 1,558,000 $0.00 1,558,000 $0.77
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
1,558,000 2035-06-05 No 4 A Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 362,877 Indirect See footnote
Footnotes
  1. The purchase was made in Euros and the price was converted into U.S. dollars based on the foreign currency exchange rate as of June 4, 2025 (at Euro 1.00 = U.S. dollar 1.1384).
  2. 362,877 shares of the Issuer's common stock are owned by Listrax UG (haftungsbeschrankt). The RP is Managing Director of Listrax UG and exercises voting and dispositive power over such shares.
  3. 25% of the shares underlying the option vest on the first anniversary of the grant date, with the remainder vesting in equal increments on each successive one-month anniversary thereafter for the next 36 months.